GAM
ALNY icon

Groupama Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Groupama Asset Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2M Buy
36,767
+889
+2% +$303K 0.18% 77
2025
Q4 		$14.3M Buy
35,878
+3,796
+12% +$1.68M 0.21% 72
2025
Q3 		$18.6M Sell
32,082
-16,303
-34% -$6.64M 0.27% 64
2025
Q2 		$17.6M Buy
48,385
+8,246
+21% +$2.28M 0.29% 64
2025
Q1 		$12.5M Buy
40,139
+11,689
+41% +$3M 0.25% 67
2024
Q4 		$8.32M Buy
28,450
+7,065
+33% +$1.86M 0.17% 83
2024
Q3 		$6.13M Sell
21,385
-2,849
-12% -$742K 0.16% 96
2024
Q2 		$5.89M Buy
24,234
+21,978
+974% +$3.47M 0.08% 120
2024
Q1 		$3.25M Sell
2,256
-15,061
-87% -$2.51M 0.06% 173
2023
Q4 		$3.32M Buy
+17,317
New +$2.95M 0.09% 146

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return